b12 injections vs sublingual treatment Efficacy of versus oral vitamin supplementation for the of vitamin B12 deficiency–A prospective randomised open label study Oral vs. Intramuscular Vitamin B12

Smoking is also a major risk factor for migraines

Fee schedules and related components are not assigned by the AMA, are not included in the CPT and the AMA has not endorsed their use

Additionally, we stated in the CY 2026 OPPS/ASC proposed rule that we believe that the pass-through payment category C1765 may also appropriately describe the Axoguard HA+ Nerve Protector TM because the device, as described by the applicant, is designed to be placed on and around neural structures to be a protective interface between a nerve and the surrounding tissue, to minimize the potential for soft tissue attachments, and to ensure the nerve's ability to glide through tissue structures during anatomic movement, and therefore may be appropriately described as an adhesion barrier consistent with devices described by C1765

Zepbound vial costs: The vials are only available when paying cash, and are not eligible for insurance coverage